Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnevist-enhanced MRA in Aortic Arch and Cerebral Branches
NCT00310609Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gadopentetate dimeglumine in Aortic arch syndrome, sponsored by Bayer. Started Dec 2003; status: completed.
02
Drugs
gadopentetate dimeglumine
03
Conditions
Aortic arch syndrome
Beyond the preview
Go deeper on NCT00310609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310609.